Budget impact analysis of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma

YANG Yun , ZHAO Na , XU Yan , ZHAO Yang

PDF(6908 KB)
主办：上海医药工业研究院
　　　中国药学会
ISSN 1672-9188   CN 31-1939/R   SLYHAA
World Clinical Drug
PDF(6908 KB)
World Clinical Drug ›› 2025, Vol. 46 ›› Issue (5) : 465. DOI: 10.13683/j.wph.2025.05.007
Article

Budget impact analysis of nivolumab and ipilimumab for the treatment of unresectable malignant pleural mesothelioma

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 46(5): 465 https://doi.org/10.13683/j.wph.2025.05.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(6908 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉